A study led by researchers at Yale Cancer Center and the University of Maryland Comprehensive Cancer Center showed that ixabepilone plus bevacizumab (IXA+BEV) is a well-tolerated, effective combination for treatment of platinum/taxane-resistant ovarian cancer compared to ixabepilone (IXA) alone. The data show it also may significantly extend both progression free survival and overall survival.
A study led by Yale Cancer Center researchers showed enfortumab vedotin is effective in patients with muscle-invasive bladder cancer not eligible for cisplatin chemotherapy.
Interim results from the single center, randomized, phase III MIRAGE trial, a UCLA-led study comparing MRIdian MRI-guided vs. CT-guided stereotactic body radiotherapy (SBRT) for localized prostate cancer, signaled superiority of MRIdian MRI-guided SBRT with a significant reduction in acute grade ≥2 GU toxicity in men receiving MRI-guided SBRT over those receiving CT-guided SBRT.
Breast cancer has surpassed lung cancer as the leading cause of cancer death among Black women as of 2019, according to a report from the American Cancer Society.
The American Association for Cancer Research released the AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care, providing a comprehensive view of the burden of COVID-19 among patients with cancer; the challenges presented by the pandemic in cancer research and patient care; and the changes implemented during the pandemic that have unexpectedly improved research practices and access to care.
Research from Sanford Burnham Prebys has revealed significant molecular differences between the breast cells of white and Black women that help explain why Black women experience higher breast cancer mortality.
Fox Chase Cancer Center researchers confirmed that the mRNA vaccines for COVID-19 are just as safe for people with cancer as they are for cancer-free individuals.
UC Davis Health has successfully treated its first patient with chimeric antigen receptor T cells created in its cellular therapy lab. UC Davis is now one of only a few medical centers in California manufacturing CAR T cells on-site.
An online symptom management tool using expressive writing could help women with ovarian cancer better manage complex symptoms, according to a new study led by a University of Pittsburgh and UPMC nurse-scientist.
Researchers at the University of Kansas Medical Center, Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center, Brown University School of Public Health, and the University of California San Francisco have introduced a novel immune-profiling method capable of reporting specific immune cell types using only DNA from blood, rather than from fresh cell samples.